Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE Jr, Walker A, Friedman HS.
Quinn JA, et al. Among authors: sampson jh.
Neuro Oncol. 2009 Oct;11(5):556-61. doi: 10.1215/15228517-2009-007. Epub 2009 Mar 16.
Neuro Oncol. 2009.
PMID: 19289491
Free PMC article.
Clinical Trial.